Morgan Stanley & Co. LLC

1585 Broadway

New York, New York 10036

United States of America

BofA Securities, Inc.

One Bryant Park

New York, NY 10036

United States of America

Cowen and Company, LLC

599 Lexington Avenue

New York, NY 10022

United States of America

As representatives of the prospective underwriters

VIA EDGAR

June 10, 2020

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

 

Attention:		Ms. Tara Harkins
		Mr. Kevin Kuhar
		Mr. Jeffrey Gabor
		Ms. Christine Westbrook
Re:		Burning Rock Biotech Limited (the “Company”)
		Registration Statement on Form F-1, as amended (Registration No. 333- 238596)
		Registration Statement on Form 8-A (Registration No. 001- 39316)

Dear Ladies and Gentlemen:

We hereby join the Company’s request for acceleration of the above-referenced Registration Statements, requesting effectiveness at 4:00 p.m., Eastern Time on June 11, 2020, or as soon thereafter as is practicable.

 

Pursuant to Rule 460 of the General Rules and Regulations promulgated under the Securities Act of 1933, as amended, we wish to advise you that between June 5, 2020 and the date hereof, copies of the Company’s Preliminary Prospectus dated June 5, 2020 were distributed as follows: 180 copies to prospective underwriters, institutional investors, dealers and others.

We have been advised by the prospective underwriters that they have complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

[Signature page follows]

 

2

[Signature Page to Acceleration Request Letter]

[Signature Page to Acceleration Request Letter]

[Signature Page to Acceleration Request Letter]